Literature DB >> 15761289

'Metastasizing pleomorphic salivary adenoma' should now be considered a low-grade malignancy with a lethal potential.

Patrick J Bradley1.   

Abstract

PURPOSE OF REVIEW: To review the current knowledge on the clinical entity of metastasizing pleomorphic adenoma. RECENT
FINDINGS: Using case studies, the literature continues to explore the potential to identify a chromosomal abnormality that might explain the clinical entity, and may constitute a submicroscopic malignant transformation with molecular genetic alterations. Presently there are no agreed histopathological parameters that can identify or confirm a difference in behavior between the 'common' pleomorphic adenoma from the metastasizing pleomorphic adenoma.
SUMMARY: The evidence supports that metastasizing pleomorphic adenoma is most likely to be an unrecognized and as yet unclassified malignant neoplasm and as such must be considered a low-grade, potentially lethal malignant disease when it presents, which may constitute a submicroscopic malignant transformation with molecular genetic alterations. Further research is required to answer the many questions.

Entities:  

Mesh:

Year:  2005        PMID: 15761289     DOI: 10.1097/01.moo.0000153450.87288.2a

Source DB:  PubMed          Journal:  Curr Opin Otolaryngol Head Neck Surg        ISSN: 1068-9508            Impact factor:   2.064


  8 in total

1.  Benign pleomorphic adenoma of the soft palate metastasizing to the sphenoid sinus.

Authors:  Chang Hoon Bae; Yong-Dae Kim; Si-Youn Song
Journal:  Clin Exp Otorhinolaryngol       Date:  2010-09-17       Impact factor: 3.372

2.  Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Tumors of the Salivary Gland.

Authors:  Raja R Seethala; Göran Stenman
Journal:  Head Neck Pathol       Date:  2017-02-28

3.  Metastatic pleomorphic adenoma to the supraspinatus muscle: a case report and review of a rare aggressive clinical entity.

Authors:  James G McGarry; Maeve Redmond; John B Tuffy; Lorraine Wilson; Seamus Looby
Journal:  J Radiol Case Rep       Date:  2015-10-31

Review 4.  Metastasizing Pleomorphic Adenoma Case Report and Review of the Literature.

Authors:  Rana Alshagroud; Amandip Kamoh; Saurin R Popat; Margaret Brandwein-Weber; Alfredo Aguirre
Journal:  Head Neck Pathol       Date:  2017-05-25

5.  Intracapsular (in situ) carcinoma ex pleomorphic adenoma with unusual clinical and histological features.

Authors:  Rajesh Logasundaram; Himan Amarawickrama; Don Premachandra; Henrik Hellquist
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-02-21       Impact factor: 2.503

6.  Metastasizing pleomorphic adenoma presenting as an asymptomatic kidney tumor twenty-nine years after parotidectomy - urological viewpoint and overview of the literature to date.

Authors:  Jan Ebbing; Carolin Blind; Harald Stein; Kurt Miller; Christoph Loddenkemper
Journal:  Rare Tumors       Date:  2009-12-28

7.  Differentiation of Benign From Malignant Parotid Gland Tumors Using Conventional MRI Based on Radiomics Nomogram.

Authors:  Jinbo Qi; Ankang Gao; Xiaoyue Ma; Yang Song; Guohua Zhao; Jie Bai; Eryuan Gao; Kai Zhao; Baohong Wen; Yong Zhang; Jingliang Cheng
Journal:  Front Oncol       Date:  2022-07-11       Impact factor: 5.738

Review 8.  2021 Update on Diagnostic Markers and Translocation in Salivary Gland Tumors.

Authors:  Malin Tordis Meyer; Christoph Watermann; Thomas Dreyer; Süleyman Ergün; Srikanth Karnati
Journal:  Int J Mol Sci       Date:  2021-06-24       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.